HealthDay on MSN50m
Anifrolumab Tied to Less Organ Damage for Patients With LupusFor patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with l ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback